论文部分内容阅读
目的评价临床路径管理模式的临床效果。方法选取该医院2010年5月-2013年5月5个实施临床路径管理病种的患者5268例(临床路径组)和同期的非临床路径管理患者5895例(传统组),对次均住院费用、平均住院日、术前平均住院日及患者满意度等指标进行综合评价。结果临床路径组与传统组比较:结节性甲状腺肿的次均住院费用、次均药费差异无统计学意义,P>0.05,但辅助检查费用显著下降,P<0.001;单纯性阑尾炎次均辅助检查费用差异无统计学意义,P=0.749;其余病种次均住院费用、平均住院日、术前平均住院日和患者满意度比较,P值均<0.05,差异有统计学意义。结论临床路径管理可以有效控制医疗费用的过快增长,缩短患者住院时间和术前等待时间,提高患者满意度。
Objective To evaluate the clinical effect of clinical path management. Methods A total of 5268 patients (clinical pathway group) and 5895 non-clinical pathway management patients (traditional group) were enrolled in this study from May 2010 to May 2013 in this hospital. The average hospitalization cost , Average length of stay, preoperative average length of stay and patient satisfaction indicators such as comprehensive evaluation. Results The clinical pathological group compared with the traditional group: nodular goiter average cost of hospitalization, the average cost was no significant difference, P> 0.05, but the cost of the auxiliary examination decreased significantly, P <0.001; simple appendicitis average There was no significant difference in the cost of auxiliary examination, P = 0.749; The average hospitalization cost, average length of stay, preoperative average length of stay and patient satisfaction, P values were less than 0.05, the difference was statistically significant. Conclusion Clinical path management can effectively control the excessive growth of medical costs, shorten the hospitalization time and preoperative waiting time, and improve patient satisfaction.